Physical and Mental Fatigability in Late Life Clinical Populations
晚年临床人群的身体和精神疲劳
基本信息
- 批准号:9155091
- 负责人:
- 金额:$ 25.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBackBehavioralChronic DiseaseClinicalCognitiveDSM-IVDataDepressed moodDiagnosisDigit structureDiseaseDysthymic DisorderElderlyEpisodic memoryExertionFatigueFunctional disorderGaitGoalsHamilton Rating Scale for DepressionImpaired cognitionIndividualInterventionInvestigationKnowledgeLeftMajor Depressive DisorderMeasuresMemoryMemory impairmentMental DepressionMental FatigueMetabolicMotivationParticipantPatient Self-ReportPerformancePhysical PerformancePopulationPsyche structureReaction TimeRecruitment ActivityRiskSeveritiesSkeletal MuscleTask PerformancesTestingValidationWalkingagedcognitive performancecognitive taskdepressive symptomsdiscountingexecutive functionimprovedinnovationkinematicsmild cognitive impairmentmortalityneuropsychologicalprocessing speedprognosticrelating to nervous systemsocialwalking speed
项目摘要
Project Summary: The primary goal of this R21 application is to establish the concurrent and discriminant
validity of physical and mental fatigability domains of the Pittsburgh Fatigability Scale (PFS) across disorders
common in late life in which fatigue is most prevalent. Fatigue is a common complaint of older adults and is
associated with chronic diseases, functional limitations,1-3 depressive symptoms,4 and mortality risk.5-11 Despite
its prognostic importance, measuring fatigue has proven methodologically challenging.5,6,12,13 The concept of
fatigability addresses these challenges by anchoring perceived exertion to a specific activity for a specific
intensity and duration.6 Recent efforts to develop a self-report measure of physical and mental fatigability in
healthy older adults have resulted in PFS.12 Higher PFS physical fatigability scores12 are associated with
greater perceived exertion and poorer physical performance. To date, however, little is known about 1) the
PFS mental fatigability domain, specifically its neuropsychological and behavioral correlates and how it relates
to physical fatigability, and 2) the validity of the use of the PFS in clinical populations common in later life. In
this R21 we will validate the PFS by testing associations of its physical and mental domains with physical and
cognitive performance, neuropsychological functioning and depression severity in participants with depression,
amnestic MCI, and/or fatigue. Cognitive performance decrements on sustained cognitive tasks have been
ascribed to mental fatigue,16-20 a phenomenon associated with decrements in physical performance as well.21
Older adults, susceptible to physical fatigability,6,12-14 may also be susceptible to mental fatigability15 as a result
of the increased neural activity required to maintain cognitive performance in later life.16,22-30 Understanding the
relationship between mental and physical fatigability on the PFS and their relationships to cognitive and
physical performance may help identify the pathophysiological mechanisms of these constructs. Validation of
the PFS however requires an investigation of the measure's performance in clinical populations in whom
fatigue is highly prevalent (Aim 2). Older adults with depressive illness31-35 and mild cognitive impairment
(MCI)36,37 represent two such populations, yet little is known about fatigability in older adults with depression or
CI. We will recruit 120 adults aged > 65 years with subjective complaints of fatigue (n = 40 with subjective
complaints of fatigue and no depression or CI; n = 40 with aMCI and no depression; n = 40 with depression
without aMCI). Participants will undergo an assessment of physical performance (measures of gait kinematics,
EMG, force plate, and metabolic data with perceived exertion during a 16-min walk) and cognitive performance
(N-back and effort-discounting tasks, episodic memory, executive functioning, and processing speed).
Validation of the PFS is necessary to 1) investigate the underlying pathophysiological mechanisms of physical
and mental fatigability across clinical populations and 2) to develop innovative interventions targeting these
mechanisms.
项目总结:这个R21应用程序的主要目标是建立并发和判别
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick J Brown其他文献
Patrick J Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick J Brown', 18)}}的其他基金
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
2/5 神经认知和神经影像生物标志物:预测晚期难治性抑郁症患者的痴呆进展。
- 批准号:
9981020 - 财政年份:2017
- 资助金额:
$ 25.72万 - 项目类别:
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
2/5 神经认知和神经影像生物标志物:预测晚期难治性抑郁症患者的痴呆进展。
- 批准号:
10001243 - 财政年份:2017
- 资助金额:
$ 25.72万 - 项目类别:
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
2/5 神经认知和神经影像生物标志物:预测晚期难治性抑郁症患者的痴呆进展。
- 批准号:
10219928 - 财政年份:2017
- 资助金额:
$ 25.72万 - 项目类别:
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
2/5 神经认知和神经影像生物标志物:预测晚期难治性抑郁症患者的痴呆进展。
- 批准号:
9755517 - 财政年份:2017
- 资助金额:
$ 25.72万 - 项目类别:
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.
2/5 神经认知和神经影像生物标志物:预测晚期难治性抑郁症患者的痴呆进展。
- 批准号:
9420328 - 财政年份:2017
- 资助金额:
$ 25.72万 - 项目类别:
The Phenomenology and Antidepressant Treatment of Depressed, Frail Older Adults
抑郁、虚弱老年人的现象学和抗抑郁治疗
- 批准号:
8581067 - 财政年份:2013
- 资助金额:
$ 25.72万 - 项目类别:
The Phenomenology and Antidepressant Treatment of Depressed, Frail Older Adults
抑郁、虚弱老年人的现象学和抗抑郁治疗
- 批准号:
8711561 - 财政年份:2013
- 资助金额:
$ 25.72万 - 项目类别:
The Phenomenology and Antidepressant Treatment of Depressed, Frail Older Adults
抑郁、虚弱老年人的现象学和抗抑郁治疗
- 批准号:
9339730 - 财政年份:2013
- 资助金额:
$ 25.72万 - 项目类别:
Research Training in Late-Life NeuroPsychiatric Disorders
晚年神经精神疾病研究培训
- 批准号:
10380616 - 财政年份:1998
- 资助金额:
$ 25.72万 - 项目类别:
Research Training in Late-Life NeuroPsychiatric Disorders
晚年神经精神疾病研究培训
- 批准号:
10591549 - 财政年份:1998
- 资助金额:
$ 25.72万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 25.72万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 25.72万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 25.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 25.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 25.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




